Anthony Bosch has lawsuit dropped by MLB

Major League Baseball has withdrawn its lawsuit against a defunct Florida anti-aging clinic at the centre of the scandal involving use of banned substances by players, including New York Yankees star Alex Rodriguez.

Biogenesis founder accused of providing players with PEDs

U.S. Federal authorities on Tuesday charged Anthony Bosch, the founder of a defunct Florida anti-aging clinic, who is accused of providing steroids and other banned substances to Major League Baseball players, including Yankees star Alex Rodriguez. (Associated Press/60 Minutes)

Major League Baseball has withdrawn its lawsuit against a defunct Florida anti-aging clinic at the centre of the scandal involving use of banned substances by players, including New York Yankees star Alex Rodriguez.

A lawyer for MLB, Matthew Menchel, confirmed Wednesday the league dropped its case against Biogenesis of America, its owner Anthony Bosch and several other individuals.

The lawsuit had accused Biogenesis and Bosch of conspiring with players to violate their contracts by providing them with banned performance-enhancing substances.

Fourteen players associated with the Coral Gables clinic were disciplined by MLB, including a season-long 2014 suspension imposed on Rodriguez.

The Yankees star recently dropped his lawsuit against MLB and agreed to serve the suspension. Although the lawsuit sought unspecified money damages, it also provided MLB a way to subpoena clinic records.

Comments

To encourage thoughtful and respectful conversations, first and last names will appear with each submission to CBC/Radio-Canada's online communities (except in children and youth-oriented communities). Pseudonyms will no longer be permitted.

By submitting a comment, you accept that CBC has the right to reproduce and publish that comment in whole or in part, in any manner CBC chooses. Please note that CBC does not endorse the opinions expressed in comments. Comments on this story are moderated according to our Submission Guidelines. Comments are welcome while open. We reserve the right to close comments at any time.